Related Experiment Video
Updated: May 18, 2026

14:49
Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
Anabolic steroids in patients undergoing total knee arthroplasty
David Metcalfe1, Evan Watts, James P Masters
1Department of Orthopaedic Surgery, University Hospital Coventry and Warwickshire, Coventry, UK.
BMJ Open
|September 25, 2012
Summary
Anabolic-androgenic steroids (AAS) show potential for improving quadriceps strength and functional scores after total knee replacement (TKR). However, more research is needed to confirm these benefits and safety for routine use.
Area of Science:
- Orthopedics
- Pharmacology
- Rehabilitation Medicine
Background:
- Total knee replacement (TKR) is a common procedure for end-stage knee osteoarthritis.
- Postoperative rehabilitation is crucial for optimal functional recovery.
- Anabolic-androgenic steroids (AAS) have anabolic properties that may aid muscle recovery and growth.
Purpose of the Study:
- To systematically review the existing evidence on the efficacy and safety of AAS in TKR rehabilitation.
- To evaluate the impact of AAS on functional outcomes, strength, and adverse events post-TKR.
Main Methods:
- A systematic review of all available clinical study designs was conducted.
- Searches were performed across multiple databases (MEDLINE, EMBASE, AMED, CINAHL, Cochrane Library) up to August 2012.
- Inclusion criteria encompassed all study designs without language or demographic restrictions, assessing functional, physiological, and administrative outcomes, and adverse events.
Main Results:
- Two small randomized controlled trials met the inclusion criteria.
- The AAS group demonstrated statistically significant improvements in quadriceps strength, Functional Independence Measure, and Knee Society Score at various time points.
- No significant differences were found in hamstring strength, bone mineral density, sit-to-stand testing, walking speed, or hospital stay. No adverse events were reported.
Conclusions:
- Current evidence is insufficient to recommend routine AAS administration for TKR patients.
- Pilot data suggest AAS may be safely administered and could improve key postoperative outcomes.
- A sufficiently powered randomized trial is warranted to confirm clinical significance.
